Enanta Pharmaceuticals (ENTA) Net Equity Issued and Repurchased (2012 - 2026)
Enanta Pharmaceuticals (ENTA) posted Net Equity Issued and Repurchased of $492,000 for fiscal Q3 2026 (quarter ended Jun 30, 2026), up 904.1% from the prior quarter.
Powered by 
Analysis
Enanta Pharmaceuticals (ENTA) Net Equity Issued and Repurchased (2012 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, Net Equity Issued and Repurchased at Enanta Pharmaceuticals was $70.68 million; for FY2025 (ended Sep 30, 2025), it came in at $145,000, down 1.4% from FY2024.
- Annual Net Equity Issued and Repurchased has declined for three consecutive fiscal years, with a five-year compound annual growth rate of -57.5% (FY2020 to FY2025).
- In prior fiscal years, Enanta Pharmaceuticals' Net Equity Issued and Repurchased was $147,000 in FY2024 (-93.3%), $2.21 million in FY2023 (-89.6%), $21.26 million in FY2022 (+488.3%) and $3.61 million in FY2021 (-65.5%).
- Quarterly Net Equity Issued and Repurchased has run from a low of $28,000 in fiscal Q3 2024 to a high of $70.09 million in fiscal Q1 2026 over five years.
- The strongest year-over-year quarter for Net Equity Issued and Repurchased in the past five years was fiscal Q3 2022, with growth of 500.6%; the weakest was fiscal Q3 2023, with a decline of 95.1%.
- According to Business Quant data, Net Equity Issued and Repurchased for the three prior fiscal quarters was $49,000 (Q2 2026), $70.09 million (Q1 2026) and $51,000 (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Equity Issued (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | -377.00 Mn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | -966.00 Mn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | -5.00 Mn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | -406.00 Mn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 4.00 Mn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | - |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | -283.00 Mn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | - |
| 10 | Enanta Pharmaceuticals | 326.73 Mn | -401.27 Mn | - | 492,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 492,000.00 |
| Mar 31, 2026 | 49,000.00 |
| Dec 31, 2025 | 70.09 Mn |
| Sep 30, 2025 | 51,000.00 |
| Dec 31, 2024 | 94,000.00 |
| Sep 30, 2024 | 68,000.00 |
| Jun 30, 2024 | 28,000.00 |
| Mar 31, 2024 | 51,000.00 |
| Jun 30, 2023 | 200,000.00 |
| Mar 31, 2023 | 882,000.00 |
| Dec 31, 2022 | 1.13 Mn |
| Sep 30, 2022 | 2.93 Mn |
| Jun 30, 2022 | 4.12 Mn |
| Mar 31, 2022 | 3.80 Mn |
| Dec 31, 2021 | 10.41 Mn |
| Sep 30, 2021 | 943,000.00 |
| Jun 30, 2021 | 686,000.00 |
| Mar 31, 2021 | 1.15 Mn |
| Dec 31, 2020 | 833,000.00 |
| Sep 30, 2020 | 233,000.00 |
API Access
Enanta Pharmaceuticals Net Equity Issued and Repurchased API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=net-equity-issued-and-repurchased&ticker=ENTA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "net-equity-issued-and-repurchased", "ticker": "ENTA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=net-equity-issued-and-repurchased&ticker=ENTA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();